What to Expect Taking Wegovy: A Realistic Week-by-Week Picture

The first pen arrives, and those first four weeks feel nothing like the adverts

Your first Wegovy pen comes at 0.25mg. That is intentional. The dose exists to let your gut adjust to a medicine that genuinely changes how your stomach empties and how hunger signals reach your brain. Most people do not lose much weight in these opening weeks, and that is completely normal. What you are likely to notice instead is a subtle shift in appetite, meals feel like enough sooner, and the background hum of thinking about food starts to quieten. Some people feel almost nothing at week one. Others feel queasy by day two.

The first week on Wegovy is typically the most unpredictable. Nausea is the most commonly reported side effect at this stage: mild for many, more disruptive for some. Eating smaller portions, avoiding fatty or very rich food, and staying hydrated all help. Constipation and a heavy, full feeling are also common. Most people find these effects ease within the first week or two, particularly if they eat slowly and avoid large meals close to the injection. The NHS semaglutide guidance lists the full range of side effects and practical self-care steps.

Worth knowing: your pen will arrive tracked by DPD in plain, unbranded packaging. The device itself is a pre-filled injection pen, simple to use, and the needle is short. Our prescribers can walk you through the technique if you are nervous about injecting.

Weeks five to twelve: when most people start to see real movement

By the time you reach the 0.5mg or 1mg step, the pattern usually becomes clearer. Appetite suppression is more consistent. Portion sizes that would once have felt inadequate now genuinely satisfy. For many people, the psychological relationship with food starts to shift, the compulsive pull toward snacking or overeating loses some of its grip. This is the GLP-1 mechanism working as designed: it is not willpower, it is biology.

Weight loss at this stage varies considerably from person to person. Metabolism, starting weight, how closely someone follows dietary advice, activity levels, all of it matters. If you want a more granular look at how progression typically unfolds, the week five picture is worth reading alongside this. The STEP 1 trial, published in the New England Journal of Medicine, followed adults over 68 weeks: average body weight reduction was around 15% at the 2.4mg maintenance dose. Not everyone reaches that figure, and some exceed it, the average is exactly that.

GI side effects at this stage often settle, though they can return temporarily after each dose increase. Fatigue, headache and dizziness are occasionally reported too, particularly if you are eating much less and not managing hydration carefully. Protein intake deserves attention: eating less overall makes it easy to under-eat protein, and that can accelerate muscle loss alongside fat loss.

Reaching the maintenance dose, and understanding what Wegovy can and cannot do alone

The standard 2.4mg maintenance dose is reached after several months of titration. Some patients remain at a lower dose if that is where they get the best balance of effect and tolerability, that is a prescriber decision, not a personal failing. How long Wegovy takes to show meaningful results depends heavily on which dose you are on and for how long.

What Wegovy does well: it reduces appetite reliably, makes it easier to sustain a calorie deficit, and for many people produces meaningful, sustained weight loss when combined with dietary change and activity. What it does not do is replace those lifestyle elements. The clinical trial results were achieved alongside a reduced-calorie diet and increased physical activity. The medicine makes the deficit easier to maintain, it does not create it independently.

There are also situations where Wegovy is not suitable. Pregnancy, breastfeeding, and planning to conceive are all contraindications; the medicine is not licensed for under-18s. For women using oral contraceptives, NHS guidance recommends discussing absorption considerations with a prescriber. The full Wegovy overview covers eligibility and contraindications in detail.

One practical note on cost: if you are thinking about the private prescription route, the Wegovy cost page explains what a legitimate price should include and what to watch for. A single transparent price covering consultation, prescription and delivery is what you should be looking for, not a headline number with extras tacked on.

What to watch out for, and when to contact someone

Most side effects on Wegovy are gastrointestinal and manageable. A smaller number require medical attention. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but potentially serious side effect of GLP-1 medicines. The symptom to act on is severe, persistent stomach pain that spreads toward the back, seek urgent medical help if that happens, especially if vomiting accompanies it.

Other things that warrant a call to your prescriber or a GP: gallbladder symptoms (sharp upper-right abdominal pain, particularly after eating), signs of a serious allergic reaction, or any significant changes in mood. You can report suspected side effects directly to the MHRA via Yellow Card.

For a closer look at how individual weeks tend to unfold across the titration journey, the Wegovy experience overview and the second-week guide are both worth reading. If you would like to discuss whether Wegovy is the right treatment for you, checking your eligibility with our prescribers is the place to start, consultations are free, and a GPhC-registered Independent Prescriber reviews every application the same day.